Categories
Health

Cramer takes Covid vaccine, urges People to enroll in a shot

CNBC’s Jim Cramer on Wednesday urged Americans to get the coronavirus vaccine soon after receiving a shot of his own.

“Today is a great day! I encourage all of you who are eligible to receive the COVID-19 vaccine,” wrote the Mad Money host on Twitter.

“One of the biggest things about a 65th birthday is the chance to get vaccinated,” added Cramer in his tweet. It was an indication of the recent change in New York policy to extend vaccine eligibility to those 65 years of age and older, as well as to younger people with compromised immune systems.

“Even if it looks like there are no more appointments, don’t be discouraged. Keep updating this page and you can make an appointment too!” wrote Cramer, who throughout the pandemic has stressed the importance of vaccines in limiting the harm caused by Covid-19.

New York announced its decision to expand the funding pool on Tuesday after the Centers for Disease Control and Prevention reissued. The move came when the launch of the U.S. vaccine was criticized for being unconvincing, in part because some Americans were reluctant to get the shot.

“I think that’s great, because one thing is certain: we have a lot more vaccines than people who take the vaccine,” said Cramer on Tuesday on Squawk on the Street.

By Wednesday morning, around 10.3 million Americans had received their first shot of the two-dose vaccine, according to the CDC. About 29.4 million cans were distributed. The Trump administration originally hoped to vaccinate 20 million people by the end of 2020.

Cramer said in another tweet on Wednesday that he received the vaccine developed by Moderna, which is one of two that has received emergency approval from the U.S. Food and Drug Administration. The other vaccine is made by Pfizer and its German partner BioNTech.

Categories
Health

New York to show Citi Subject into ‘mega’ Covid vaccination web site: Mayor

Citi Field Ballpark, home of the New York Mets Major League Baseball team on September 7, 2019 in Flushing, Queens, New York City.

Tim Clayton | Corbis Sport | Getty Images

New York will turn Citi Field into a 24/7 mega coronavirus vaccination site by the end of January to vaccinate thousands of residents every day, Mayor Bill de Blasio announced on Tuesday.

NYC Health and Hospitals will operate the New York Mets site with the goal of taking between 5,000 and 7,000 admissions daily, de Blasio said in a joint announcement with Mets owner Steve Cohen.

The announcement comes a day after Los Angeles Mayor Eric Garcetti announced that his city will set up a vaccination site at Dodger Stadium by the end of this week. This facility can fire up to 12,000 shots a day, according to a statement from Garcetti’s office on Monday.

“This will help so many people get vaccinated,” de Blasio said during a press conference. “We welcome all New Yorkers. We even welcome Yankees fans. There is no discrimination.”

New York City Mayor has urged Governor Andrew Cuomo to increase the number of people who would be eligible for a coronavirus vaccine, beyond the priority healthcare workers. Cuomo granted the city’s request last week, saying that people age 75 and older, as well as key workers such as first responders, teachers, school staff and others across the state could be vaccinated against the disease starting this week.

A person wearing a protective mask stands in front of a vaccination center for Covid-19 in Bathgate Industrial Park in the Bronx, New York on Monday, January 11, 2021.

David Delgado | Bloomberg | Getty Images

As of Tuesday, the state will open Covid-19 vaccinations to all over 65s as well as to younger people with compromised immune systems, the Democratic governor said during a conversation with reporters on Tuesday morning.

However, it seems that so far the problem has not found a place for people to be vaccinated – it has ensured the supply of the doses. According to Cuomo, the newly expanded federal guidelines apply to about 7 million people, but the state only receives about 300,000 doses per week.

“I ask for your patience, as there are unfortunately far more eligible New Yorkers than vaccines from the federal government,” Cuomo said in a tweet on Tuesday.

De Blasio said the city had 26,000 vaccinations on Monday. At that rate, the city will run out of vaccines in less than two weeks, he said.

“We’re going to need the doses to keep this kind of effort going,” he said.

Categories
Health

China Locations Over 22 Million on Lockdown Amid New Covid Wave

When a handful of new coronavirus cases emerged in a province around Beijing earlier this month – apparently spread at a wedding reception in the village – the Chinese authorities took action.

They locked down two cities with more than 17 million people, Shijiazhuang and Xingtai. They ordered a crash test regime for almost every resident, which was completed within a few days.

They stopped transportation and canceled weddings, funerals and, most importantly, a conference of the Communist Party in the province.

This week, the locks were expanded to include another city on the outskirts of Beijing, Langfang, and a county in Heilongjiang, a northeastern province. The districts in Beijing, the Chinese capital, were also closed.

In total, more than 22 million people have been ordered to stay in their homes – twice as many as last January when the Chinese central government locked Wuhan, the downtown area where the virus was first reported, in what was considered exceptional at the time.

The flare remains small compared to the devastation in other countries, but it threatens to undermine the country’s Communist Party’s success in fighting the virus, sending the economy back on track after last year’s slump and the population comes back close to normal life.

The urgency of the government’s current response contrasts with that of officials in Wuhan last year, who feared a backlash if they exposed the mysterious new diseases that then emerged. Local officials had held a Communist Party conference there, but it has now been canceled in Hebei despite knowing the risk of the disease spreading among the people.

Since Wuhan, authorities have created a playbook that mobilizes party cadres to respond quickly to new outbreaks by sealing off neighborhoods, running extensive testing, and quarantining large groups if necessary.

“In the prevention and control of infectious diseases, one of the most important points is to seek the truth from facts, to openly and transparently share epidemic information and never to allow it to be covered up or underreported,” said Chinese Premier Li Keqiang at a meeting on Friday the State Council, China’s Cabinet.

China, a country of 1.4 billion people, has reported an average of 109 new cases per day over the past week, according to a New York Times database. Those would be welcome numbers in countries where things are far worse – including the United States, which averages more than 250,000 new cases a day – but they’re the worst in China since last summer.

China’s National Health Commission has not reported any new deaths, but the World Health Organization, using information from China, has recorded 12 so far in 2021. The National Health Commission did not respond to requests to explain the discrepancy.

In Hebei, the province where the new outbreak has concentrated, officials declared a “state of war” last week with no signs of an early lifting.

During the pandemic, officials were particularly concerned about Beijing, home to the central leadership of the Communist Party. Last week, Hebei Party Secretary Wang Dongfeng pledged to ensure that the province is “the moat for Beijing’s political security.”

The outbreaks, which have occurred with minimal cases after such a long time, have heightened concern across China, where residents in most places felt the pandemic was a thing of the past.

New cases have also been reported in northern Shanxi Province and northeastern Heilongjiang and Jilin provinces. Shanghai urged residents not to leave the city on Wednesday, announcing that those who had traveled to risk areas would be quarantined for two weeks and only leave after two tests, while those who had traveled to areas with At the highest risk, government facilities were quarantined.

Updated

Jan. 13, 2021, 9:04 p.m. ET

Rumors swirled in Wuhan that the city might face another lockdown; While these appeared unfounded, the officials noticeably tightened temperature controls on some streets.

In Shunyi, a district in northeast Beijing that includes Beijing Capital International Airport and rural villages, residents have been ordered to stay indoors since a spate of cases just before the New Year. At Beijing’s main train stations, workers sprayed disinfectant in public spaces.

After a taxi driver tested positive in Beijing over the weekend, authorities tracked down 144 passengers for additional tests, according to The Global Times, a state tabloid. Now anyone who gets into a taxi or car service in Beijing has to scan a QR code from their phone so that the government can quickly track them down.

The government has pushed ahead with plans to vaccinate 50 million people before next month’s New Year celebrations, a holiday that traditionally hundreds of millions of people cross the country to visit their families. More than 10 million cans had been distributed by Wednesday.

Despite the vaccinations, officials have already warned people not to travel before vacation.

“If these measures are well implemented, it can ensure that there is not a major epidemic recovery,” Feng Zijian, deputy director of the Chinese Center for Disease Control, said at a briefing in Beijing on Wednesday.

While the new restrictions have pestered millions, there doesn’t seem to be any significant public opposition to them.

“In my opinion, measures like a city-wide lockdown are actually pretty good,” said Zhao Zhengyu, a Beijing university student who now lives in her parents’ home in Shijiazhuang, where she was on winter hiatus when the outbreak broke out there.

Many in the city feared a repeat of Wuhan’s lockdown, but it sounded unimpressed.

Ms. Zhao’s parents now work from home and only collect groceries from a market in their residential area. She complained that she couldn’t meet friends or study in the library, but said that online learning had become routine.

“Maybe we’ve gotten used to it,” she said.

The response underscored how quickly the government is mobilizing its resources to contain outbreaks.

After the lockdown was announced in Shijiazhuang on January 6, authorities collected more than 10 million coronavirus test samples over the next three days – almost one for every resident, officials said at a press conference in the city. These tests gave 354 positive results, although some of the cases were asymptomatic.

A second round of mass nucleic acid testing began on Tuesday.

“In fact, this is a kind of war system – that uses wartime social control in peacetime – and that war system works during a pandemic,” said Chen Min, a writer and former newspaper editor who goes by the pseudonym Xiao Shu. Mr. Chen was in Wuhan last year when the city was locked down.

The way the country was governed gave him the means to fight the epidemic – even if some measures seemed excessive.

“Chinese cities are enforcing housing systems – smaller ones have hundreds of residents, large ones tens of thousands – and if you close the gates you can lock in tens of thousands of people,” Chen said in a telephone interview. “If you run into this type of problem now, you will surely use this method. That would be impossible in western countries. “

Chris Buckley and Keith Bradsher contributed to the coverage. Claire Fu contributed to the research.

Categories
Health

New York state will open Covid vaccinations to everybody 65 and over, Gov. Cuomo says

New York Governor Andrew Cuomo speaks out on Coronavirus Disease (COVID-19) on November 15, 2020 at Riverside Church in Manhattan, New York City, United States.

Andy Kelly | Reuters

New York State will accept new federal guidelines to open the approval of Covid vaccines to anyone over the age of 65 as well as younger people with compromised immune systems, Governor Andrew Cuomo said Tuesday.

The governor accepted the new guidelines, which Cuomo said came from the Centers for Disease Control and Prevention, and also criticized the move. He said demand will quickly outstrip supply. The state had previously given priority to health workers and recently extended the eligibility to those aged 75 and over.

Cuomo said expanding it further to 65 and older would open the eligibility to about 7 million people, but the state only receives about 300,000 doses a week.

“We will accept the federal guidelines,” Cuomo said on a conference call with reporters. “I don’t want New Yorkers to believe that we are not doing everything we can to qualify them for the vaccine because I want to keep the people of New York as calm as we can keep people in these anxious times.”

Cuomo said the state is still facing a “drop, drop, drop from the faucet of federal dosage availability” that is inhibiting the state’s ability to vaccinate people. The federal government has withheld more than half of all available vaccine doses to ensure enough second booster vaccinations are needed to achieve maximum immunity.

But the Trump administration will announce Tuesday that the government will begin distributing these doses to states, a senior government official told CNBC.

This is the latest news. You can find updates here.

Categories
Business

Covid variant present in South Africa ‘might evade’ Eli Lilly’s antibody drug: CEO

Dave Ricks, chairman and CEO of Eli Lilly, told CNBC on Tuesday that he expected the company’s Covid-19 antibody drug to be effective against the variant of coronavirus found in the UK

However, he said the exposure observed in South Africa is likely to be more of a challenge.

“The South African variant … is cause for concern. It has more dramatic mutations to the spike protein that these antibody drugs target,” Ricks told Squawk Box. “In theory, it could evade our drugs.”

Eli Lilly’s antibody drug was approved for emergency use by the US Food and Drug Administration in November. The drug is aimed at people recently diagnosed with Covid-19 in hopes of preventing the need for hospitalization. Regeneron’s Covid-19 antibody treatment, which President Donald Trump received after contracting the disease, has also received limited approval from the FDA.

According to Ricks, Eli Lilly wants to work with the FDA to quickly test different versions of antibodies to see if they are against virus variants like the one in South Africa.

“We actually have a large library of these antibodies now that are pre-clinical,” said Ricks. “We could think of a very expedited way to study them in a month or two and then approve their use. That seems like a smart thing because this virus is mutating.”

Discovery of variants

Coronavirus variants originally found in the UK and South Africa have received significant attention in recent weeks. They are believed to be more transmissible – but not more deadly – than previous tribes. Even so, a more contagious virus that leads to more infections could continue to weigh on healthcare systems and lead to more deaths.

The discovery of these mutations also coincides with the introduction of Covid-19 vaccines from drug companies such as Pfizer and BioNTech, as well as Moderna. It has led to some questions about whether the vaccines – along with treatments for the disease – would keep their effectiveness.

In a CNBC interview on Monday, Dr. Ugur Sahin, CEO of BioNTech, confident that his vaccine, manufactured in partnership with Pfizer, will work against the strains of the virus found in the UK and South Africa.

Daniel O’Day, CEO of Gilead Sciences, told CNBC it was testing its remdesivir treatment against these new strains, but said Monday the antiviral drug would likely be effective. Antiviral drugs like remdesivir try to prevent the virus from replicating. In contrast, antibodies like Eli Lillys bind to the virus present in the body and try to neutralize it.

There have been no confirmed cases of the variant, which was first discovered in South Africa in America, but according to the Wall Street Journal, it was discovered in countries like Japan, South Korea, and Switzerland. According to the Centers for Disease Control and Prevention, there have been around 70 confirmed cases of the coronavirus variant in the US that were originally found in the UK.

“It seems clear that Lilly’s single antibody, and likely Regeneron’s cocktail, will stop this as well as the normal variant,” said Ricks of the UK-affiliated tribe. “We haven’t done a clinical study of this effect, but we do have pre-clinical data that strongly suggests that it won’t be a problem.”

Use of antibody therapies

After the FDA approved emergency use for their antibody therapies to Eli Lilly and later Regeneron, problems arose with actually delivering the drug, which requires an intravenous infusion, to Covid patients. In mid-December, CNBC reported that between 5% and 20% of the doses delivered had been administered.

That number is “climbing” now, Ricks said on Monday. He pointed to Alabama as a state where the antibodies are widespread. Alabama “basically runs out and refills every week,” he said.

“There are quite a few” from state to state, Ricks admitted. “We want all states to learn from these practices and really be able to use this medicine, as the benefit is that patients, especially seniors, are kept out of the hospital. We know if you are a senior and have Covid-19 and end up in a hospital hospital bed, the prospects are not good. “

Categories
Health

Chugai soars after UK says drug reduces hospital time for Covid sufferers

The Chugai Pharmaceutical Co. company logo will be displayed on Monday, August 18, 2014 at the headquarters of Chugai Pharma Manufacturing Co. in Tokyo, Japan.

Kiyoshi Ota | Bloomberg via Getty Images

SINGAPORE – Shares in Japanese drug maker Chugai Pharmaceutical rose sharply in trading Tuesday after the UK government found the drug tocilizumab was effective in reducing the risk of death and hospital stay for Covid patients.

In trading on Tuesday morning, Chugai’s shares rose 16.26%. The stock has since trimmed some of those gains, but is still trading 7% higher. Tuesday was the first trading day of the week for Chugai shares as Japanese markets were closed on Monday for a holiday.

In a press release on Thursday, the UK said the results of a government-funded clinical trial showed that tocilizumab was among two drugs that “reduced the relative risk of death by 24% when given to patients within 24 hours of entering the intensive care unit was administered “.

The press release also states that patients who received the drugs typically used to treat rheumatoid arthritis “left the intensive care unit an average of 7 to 10 days earlier”.

UK Health and Welfare Secretary Matt Hancock said the results were “another milestone in finding a way out of this pandemic”.

The government also said it will start promoting tocilizumab use in patients admitted to the intensive care unit. NHS will also be working with manufacturer Roche to ensure treatment remains available to UK patients.

Tocilizumab, marketed as Actemra or RoActemra, is part of a joint development between Roche and Chugai. Roche is also the majority shareholder in Chugai.

Last week, Prime Minister Boris Johnson put England on hold to contain a variant of Covid-19 that is more contagious than previous strains.

Coronavirus infection rates continue to rise in many parts of the world even as countries start introducing vaccinations. As a result, some governments have reintroduced social distancing restrictions.

To date, the disease has infected at least 90.8 million people and killed more than 1.9 million people worldwide, according to Johns Hopkins University.

Categories
Business

World Well being Group holds press briefing as international locations face Covid mutations

[The stream is slated to start at 12:00 p.m. ET. Please refresh the page if you do not see a player above at that time.]

World Health Organization officials hold a press conference on the coronavirus pandemic on Monday as more countries report cases of contagious new mutations of the virus.

The Japanese National Institute of Infectious Diseases found a new variant of the coronavirus in four passengers from Brazil on Sunday. The institute said the new strain appears to have some of the same properties, such as increased infectivity, as other variations discovered in the UK and South Africa.

The United States has now found at least 63 Covid-19 cases with the new, contagious strain of the virus, first identified in the UK and known as B.1.1.7, the Centers for Disease Control and Prevention said on Friday. The variant doesn’t appear to make patients sick or increase their risk of death, health officials have said.

The coronavirus has infected more than 90.4 million people worldwide and killed at least 1.9 million people, according to Johns Hopkins University.

– CNBC’s Sam Meredith contributed to this report.

Read CNBC’s live updates for the latest news on the Covid-19 outbreak.

Categories
Health

Johnson & Johnson Covid vaccine: Analysts are cautiously optimistic

Illustration of the Johnson & Johnson coronavirus vaccine

Given Ruvic | Reuters

LONDON – Health systems around the world are struggling to cope with the rising number of Covid-19 infections as they race against the clock to vaccinate the vulnerable.

The three vaccines currently approved for use in large Western economies all require two separate vaccinations. Given the limited supply, governments are considering controversial tactics such as increasing the time between doses in order to get at least one dose to as many people as possible.

A one-shot vaccine could vastly improve our ability to fight the virus – and we may have one soon.

J & J’s late trial

Johnson & Johnson is expected to deliver preliminary late-stage study results for its single-dose Covid vaccine candidate by the end of January. If the push turns out to be safe and effective, the company will aim to have at least 1 billion doses by the end of the year.

The J&J vaccine was developed by the company’s Belgian unit, Janssen Pharmaceutica, and is based on adenovirus viral vector technology, the same approach used to make the Oxford-AstraZeneca University vaccine. This type of shot is easier to scale than those developed by Pfizer-BioNTech and Moderna, which are based on messenger RNA technology.

Shore Capital health analyst Adam Barker said in an email to CNBC last week, “The J&J vaccine is more like the AstraZeneca vaccine, but uses only one dose. So we know this approach works (viral vector) and we know the goal will work. But we have to see what a dose does. “

The Morgan Stanley health team said in a research report released last week that J & J’s vaccine “offers unique elements and efficacy that could be positive compared to AstraZeneca, increasing confidence in pandemic response and recovery Strengthens the market “.

The investment bank is confident in the vaccine’s safety profile, given early trial data, “along with the previous success and safety profile demonstrated in its Ebola vaccine and research use in HIV, RSV and Zika”.

A report by the Tony Blair Institute for Global Change, founded by the former UK Prime Minister, calls the AstraZeneca and Johnson & Johnson jabs “the two workhorse vaccines” because they should be widely available and easier to administer than those mRNA shots.

With J & J’s technology, the vaccine is estimated to be stable for at least three months at normal refrigeration temperatures, so no new infrastructure is required for transportation.

Expected timeline

On December 17th, J & J completed the registration of its phase 3 clinical trial with 45,000 participants for its single-dose vaccine candidate. Preliminary data from the study is expected to be available by the end of the month.

If the data suggests the vaccine is safe and effective, the company is expected to file an application for approval for emergency use with the U.S. Food and Drug Administration in February. Other health regulatory applications around the world are expected to be paralleled.

Supply contracts

The company is committed to selling the vaccine on a non-profit basis for emergency use.

J&J entered into an agreement with the United States in August 2020 to supply 100 million doses of the vaccine after FDA approval or approval and the option to purchase up to 200 million additional doses under a subsequent agreement.

The UK negotiated a deal in August to purchase an initial 30 million doses of the J&J vaccine, with the option to purchase up to 22 million additional doses. The EU signed a contract with J&J in October to supply up to 400 million cans.

J & J has also agreed to provide up to 500 million doses of its vaccine to lower-income countries through COVAX under a fundamental agreement with The Vaccine Alliance (Gavi), which is responsible for equitable access to vaccines. These doses will be distributed through 2022, when the vaccine candidate is approved for use.

“If J & J’s Ad26 platform is able to achieve over 80% efficacy from a single dose, we would consider that a compelling result given the vaccine’s favorable handling requirements and significant manufacturing scale,” said Morgan Stanley.

Jonathan Reiner, Professor of Medicine and Surgery at the George Washington University School of Medicine and Health Sciences, argues, “The J&J vaccine is why we shouldn’t ditch the two-dose strategy for Pfizer-BioNTech and Moderna. We’ll probably have all the vaccines we need. We need to focus on getting the vaccines into our arms. “

Categories
Health

6 Months Later, Covid Survivors Stricken by Well being Issues

Most of the symptoms in the Wuhan report were slightly more common in women. 81 percent reported at least one health problem, compared with 73 percent for men.

Reports of other respiratory illnesses like the 2003 outbreak of SARS, another type of coronavirus, suggest that some Covid survivors may experience after-effects for months or years. Most SARS patients recovered physically, but the researchers found that many had “worrying depression, anxiety, and post-traumatic symptoms” a year later.

Commenting on the Lancet study, researchers from Italy wrote that 38 percent of SARS survivors had decreased the flow of oxygen from their lungs 15 years later, adding that “Evidence of previous coronavirus outbreaks suggests some degree Lung damage could persist ”.

While people hospitalized for Covid may have more serious or prolonged physical problems, increasing evidence shows that even people who have never been hospitalized may have residual symptoms. Many of these patients seek care in the post-Covid clinics in the United States.

A recent survey by a patient-led research team included 3,762 participants, mostly women, from 56 countries, most of whom had not been hospitalized. Nearly two-thirds said they had symptoms for at least six months, with most saying they were tired and their symptoms got worse after physical or mental exertion, the report, which was not peer-reviewed. More than half of those affected said they had “cognitive dysfunction” with brain fog or difficulty thinking or concentrating.

Dr. Peluso noted that most Wuhan patients were hospitalized in the first half of 2020 and most were not treated with newer therapies like remdesivir or dexamethasone. It is therefore unclear whether people who received these treatments would now receive the same level of long-term term complications.

Even so, he and other doctors said the study’s portrait of persistent symptoms is true. Dr. Ferrante said that in the post-Covid recovery program where she treats patients, “pretty much everyone I see reports impaired physical or cognitive function, or both.”

[Like the Science Times page on Facebook. | Sign up for the Science Times newsletter.]

Categories
Health

World Well being Group holds press convention on Covid pandemic

[The stream is slated to start at 11:00 a.m. ET. Please refresh the page if you do not see a player above at that time.]

World Health Organization officials hold a press conference on Friday to inform the public about the coronavirus outbreak, which has infected more than 88.2 million people worldwide, as governments battle to introduce vaccines.

The briefing comes as the United States announced its deadliest day of the pandemic to date, killing more than 4,000 people in one day. Around the world, governments who have received doses of vaccines manufactured by Moderna and Pfizer-BioNTech are trying to fire off shots as quickly as possible.

WHO officials and immunologists around the world are closely monitoring the genomic sequence of the virus as new variants spread in some parts of the world. A strain first discovered in the UK has spread to the US and other countries, although it has not yet finally taken root outside of the UK

Another strain, first spotted in South Africa, worries experts that vaccines and certain Covid-19 treatments may not be as effective against this strain as others.

Read CNBC’s live updates for the latest news on the Covid-19 outbreak.